Le Lézard
Classified in: Health
Subject: TDS

The Oncology Institute of Hope and Innovation Will Have an Open House for Their Henderson, Nevada Location on May 1, 2019


HENDERSON, Nev., April 25, 2019 /PRNewswire-PRWeb/ -- The Oncology Institute of Hope and Innovation Henderson, Nevada's Open House - Lead by Dr. Sanda Morar, Dr. Gilbert Nyamuswa and Dr. Shahid Malik, M.D. will occur on May 1, 2019, from 3 p.m.-5 p.m.

The new location provides extensive services including state-of-the-art infusion centers, chemotherapy educational sessions, in-house support groups, dietary and nutritional counseling, financial counseling, clinical trials, and comprehensive lab testing.

The Henderson office is located 10001 S. Eastern Ave., Suite 301, Henderson, NV 89052. The office is conveniently located close to Dignity Health - St. Rose Dominican, Siena Campus.

To attend the Open House, please call (702) 852-2017 and RSVP with Ashley or Nina.

About The Oncology Institute
Founded in 2007, The Oncology Institute of Hope and Innovation is dedicated to excelling in cancer prevention, diagnosis, and education. As the largest private practice cancer center in California, The Oncology Institute continues to provide extensive services including state-of-the-art infusion centers, chemotherapy educational sessions, in-house support groups, dietary and nutritional counseling, in-house pharmacy, financial counseling, clinical trials, comprehensive lab testing, and end of life counseling. They also offer support programs to help patients and families cope with the challenges brought on by cancer. Today, the Oncology Institute has served over 100,000 patients throughout 27 locations in Southern California, 4 in Arizona and 2 in Nevada. For more information please visit http://www.theoncologyinstitute.com.

 

SOURCE The Oncology Institute of Hope and Innovation


These press releases may also interest you

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...

at 17:21
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...



News published on and distributed by: